EU invests 10 million euro in unlocking technologies for key research in structural biology


To enable researchers from European institutes to extend innovative structural biology research, the EU has invested 10 million euro to iNEXT-Discovery, through its Horizon 2020 program. The iNEXT-Discovery consortium, coordinated by Prof. Dr. Anastassis Perrakis from the Netherlands Cancer Institute and Oncode Institute, aims to facilitate the generation of knowledge for the development of new drugs, advanced vaccines, novel biomaterials, engineered enzymes for food production, efficient biofuels, and other benefits. iNEXT-Discovery will do this by enabling leading European facilities to offer advanced technological instrumentation and expertise to all European scientists, allowing them to perform high-end structural biology research with state-of-the-art equipment that is often unavailable in their home countries.

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.